Ritalin LA "approvable" letter
Executive Summary
Novartis and Celgene expect to launch once-daily formulation of methylphenidate (Ritalin LA) during the fourth quarter after responding to Oct. 2 "approvable" letter from FDA
Novartis and Celgene expect to launch once-daily formulation of methylphenidate (Ritalin LA) during the fourth quarter after responding to Oct. 2 "approvable" letter from FDA. |